GleanMark

EARLI Trademark

EARLI is a USPTO trademark filed by Earli Inc.. Status: Registered.

Trademark Facts

MarkEARLI
Serial Number88020634
Registration Number7000700
StatusRegistered
Filing Date2018-06-29
Registration Date2023-03-14
Mark TypeWord
Nice Classes001 (Chemicals)
OwnerEarli Inc.
Attorney of RecordConnie L. Ellerbach
Prosecution Events51
Latest EventNRCC on 2023-03-14

Goods & Services

Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use | Pharmaceutical and veterinary preparations and products for the prevention, detection, localization, and treatment of cancer, respiratory diseases, and liver diseases; Drug delivery agents in the form of compounds that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, respiratory diseases, and liver diseases

Related